We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil
‹ An tOrd Gnó - Order of Business

Cancer drug reimbursement delays

Summary

Joan Collins complained about two-tier delays in approving cancer drug reimbursement between public and private patients. The Taoiseach said he had arranged a meeting with Professor Michaela Higgins and would revert back.

In May, there was a report on the two-tier system for cancer treatment, the issue being the two-year difference in the approval times for reimbursement of new cancer drugs of the public and private systems. As I said at the time, there should be no differences in people's ability to gain access to life-saving treatment based on how much money they have. I am sure the Minister of State agrees. Professor Michaela Higgins, president of the Irish Society for Medical Oncology, has stated:

It means we know we are prescribing medication for our patients that are proven to be less effective and to provide them with a poorer chance of survival and, in some cases, a poorer quality of life.

When I raised the issue with the Taoiseach, he said he would make a direct inquiry to Professor Higgins on this matter and get back to me. He has not done so. What was the result of the inquiries and what does the Government plan to do to end the two-tier system of cancer treatment?

Comment on this
Simon Harris The Taoiseach Fine Gael

Truthfully, as recently as yesterday at my diary meeting we agreed to have a meeting with Professor Higgins. I have been seeking to have that meeting for some time and it should now be scheduled. I certainly spoke to my team about it yesterday, and I will be very happy to revert to the Deputy on it.

Comment on this